Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |